» Authors » Candice Muller

Candice Muller

Explore the profile of Candice Muller including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 35
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Querry M, Botzung A, Sourty M, Chabran E, Sanna L, Loureiro de Sousa P, et al.
Int J Geriatr Psychiatry . 2025 Feb; 40(3):e70058. PMID: 40011213
Objectives: Depressive symptoms are frequent in the early stages of dementia with Lewy bodies (DLB), and more than half of DLB patients would have a history of depression. Our study...
2.
Gabriel V, Bousiges O, Mondino M, Cretin B, Philippi N, Muller C, et al.
Geroscience . 2025 Jan; PMID: 39821801
The differential mechanisms between proteinopathies and neurodegeneration in Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) remain unclear. To address this issue, we conducted a voxel-based morphometry and cerebrospinal...
3.
Tisserand A, Blanc F, Muller C, Durand H, Demuynck C, Ravier A, et al.
Brain Commun . 2024 Aug; 6(4):fcae272. PMID: 39210911
Although deficits in learning and retrieving new information are well characterized in dementia with Lewy bodies, autobiographical memory has never been explored in this disease. Yet, autobiographical memory impairments are...
4.
Gommel G, Jeanjean-Dormegny L, de Crespin de Billy C, Mainberger O, Moreau A, Obrecht A, et al.
Geroscience . 2024 Aug; PMID: 39110325
Identifying and validating a biomarker with high specificity in early-stage dementia with Lewy bodies (DLB) using a feasible method is crucial to enhance the current suboptimal diagnostic procedure. Previous research...
5.
Wurtz M, Dormegny L, Muller C, Bourcier T, Ballonzoli L, Gaucher D, et al.
Retina . 2024 Aug; 44(11):1891-1898. PMID: 39102743
Purpose: To compare two drainage techniques in macula-off retinal detachment surgery: perfluorocarbon liquid (PFCL)-assisted drainage and partial subretinal fluid drainage without PFCL. This study investigated morphological and functional outcomes, focusing...
6.
Vrillon A, Bousiges O, Gotze K, Demuynck C, Muller C, Ravier A, et al.
Alzheimers Res Ther . 2024 Jul; 16(1):146. PMID: 38961441
Background: Increasing evidence supports the use of plasma biomarkers of amyloid, tau, neurodegeneration, and neuroinflammation for diagnosis of dementia. However, their performance for positive and differential diagnosis of dementia with...
7.
Querry M, Botzung A, Cretin B, Demuynck C, Muller C, Ravier A, et al.
Geroscience . 2024 May; 46(6):5725-5744. PMID: 38750385
Dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) are often associated with depressive symptoms from the prodromal stage. The aim of the present study was to investigate the neuroanatomical...
8.
Tisserand A, Blanc F, Mondino M, Muller C, Durand H, Demuynck C, et al.
Alzheimers Res Ther . 2024 Apr; 16(1):85. PMID: 38641653
Background: Dementia with Lewy bodies (DLB) is characterized by insular atrophy, which occurs at the early stage of the disease. Damage to the insula has been associated with disorders reflecting...
9.
Bousiges O, Lavaux T, Demuynck C, Schaeffer-Agalede C, Philippi N, Muller C, et al.
Neuropathol Appl Neurobiol . 2024 Feb; 50(1):e12961. PMID: 38363175
Background: Chromogranin A (CgA) seems to be involved in the pathophysiology of different neurodegenerative pathologies such as Alzheimer's disease (AD) and dementia with Lewy Bodies (DLB). CgA is present in...
10.
Bousiges O, Cretin B, Muller C, Botzung A, Sanna L, Anthony P, et al.
Geroscience . 2023 Aug; 46(2):1527-1542. PMID: 37653269
ApoE4 as a risk factor for dementia with Lewy bodies (DLB) is still an issue. We sought to determine the involvement of ApoE4 according to different clinical parameters in our...